Ushiku, Japan

Yasunori Ikeda


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Ushiku, JP (1992)
  • Ibaraki, JP (1996)

Company Filing History:


Years Active: 1992-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yasunori Ikeda: Innovator in Tissue Plasminogen Activator Analog Development

Introduction

Yasunori Ikeda is a notable inventor based in Ushiku, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of tissue plasminogen activator (t-PA) analogs. With a total of two patents to his name, Ikeda's work focuses on enhancing the specificity and efficacy of t-PA for therapeutic applications.

Latest Patents

Ikeda's latest patents include innovative modifications to tissue plasminogen activator analogs. One patent describes t-PA analogs that contain the growth factor domain of native t-PA, with at least one cysteine residue replaced by another amino acid. These analogs may also include various substitutions and modifications, along with pharmaceutical compositions that contain one or more of the t-PA analogs combined with a physiologically acceptable carrier or diluent. Another patent highlights modified t-PA analogs that exhibit greater specificity for fibrin than native t-PA. This innovation involves replacing the K1 domain of native t-PA with another kringle domain, which mediates the binding of the analog to fibrin. The kringle in these analogs contains six cysteine residues, and similar to the previous patent, they may also include various substitutions and modifications.

Career Highlights

Yasunori Ikeda is associated with Zymogenetics, Inc., where he continues to advance research in the field of biotechnology. His work has the potential to significantly impact therapeutic strategies for conditions requiring fibrinolysis.

Collaborations

Ikeda collaborates with esteemed colleagues, including Eileen R Mulvihill and Shinji Yoshitake, who contribute to the innovative research environment at Zymogenetics, Inc.

Conclusion

Yasunori Ikeda's contributions to the development of tissue plasminogen activator analogs demonstrate his commitment to advancing medical science. His innovative patents reflect a deep understanding of biochemistry and a dedication to improving therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…